ES75
TEAS SECTION 71 & 15 RECEIVED
07/20/2026
Back to search
Official data from USPTO
PHARMAAMERICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/20/2026
Trademark type
Combined
Nice classes
5
Filing date
11/17/2018
Registration date
07/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2020
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
Singapore, SG
Examiner
AVENT, TEAGUE A
Law office
N80
Current location
TMO LAW OFFICE 126
Mark description
The mark consists of a three-dimensional configuration of packaging for the goods consisting of a rectangular-shaped box. The box consists of the stylized word "PHARMAAMERICA" with a horizontal line running along the top and a horizontal line with stars within the line running along the bottom of the word "PHARMAAMERICA". On the left side of the box are diagonal stripes with one stripe containing 5 stars. On the right side of the box there are also diagonal stripes, with one stripe being larger than the others. The broken lines depicting the outline of the box indicate placement of the mark on the packaging for the goods and are not part of the mark.
Holders and representatives
Holders
PACIFIC PHARMACEUTICALS PTE LTD
Pacific Pharmaceuticals USA, Inc.
Representatives
Sang N. Dang BLUE CAPITAL LAW FIRM, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical drugsantipyreticsanti-infectivesantineoplasticsdiureticspharmaceutical preparations for the treatment of immune system disordersdisorders of the central nervous systemendocrine disordersgastrointestinal diseasesdermatological diseasesinfectious diseasescardiovascular diseasesrespiratory diseases; mineral dietary supplements for humans
Publications
History of USPTO decisions and trademark events.
31 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/21/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/11/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
11/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/21/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2020
PUBO
PUBLISHED FOR OPPOSITION
05/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
ALIE
ASSIGNED TO LIE
03/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/16/2020
GNRT
NON-FINAL ACTION E-MAILED
03/16/2020
CNRT
NON-FINAL ACTION WRITTEN
03/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2019
RFNT
REFUSAL PROCESSED BY IB
07/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/24/2019
RFRR
REFUSAL PROCESSED BY MPU
06/24/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2019
CNRT
NON-FINAL ACTION WRITTEN
06/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2019
DOCK
ASSIGNED TO EXAMINER
05/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/23/2019
Continuous trademark protection
Get notified about every new filing that threatens PHARMAAMERICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.